In April, UPS agreed to pay $40 million to U.S. authorities and admitted doing business with illegal online pharmacies in a deal that kept it from being prosecuted. Competitor FedEx is also a target of the investigation but does not intend to roll over so easily.
The industry is headed toward some form of track-and-trace in the U.S. but what shape it will take and whether it will get to the unit level is the question on everyone's mind. A bill advancing in the U.S. Senate would make that happen sooner than later, but the U.S. House has pushed through a proposal that would put off that level of drug monitoring for more than a decade.
The FDA and U.S. law enforcement are continuing their crackdown on Internet sales of illegally imported drugs, even enlisting the help of Interpol and police in London and Germany to track and arrest two Pakistani men accused of selling controlled substances online.
China has often been maligned in Africa as the source of counterfeit drugs, a reputation that the government is not at all happy about. Chinese authorities this year even took the unusual step of defending their country against a report in a U.K. newspaper that it was a primary source of fake antimalarial drugs in Uganda and Tanzania.
Counterfeit drugs manufactured in China and sold in the U.S. have become a plague on the industry, but China also suffers from counterfeits being sold to its own citizens.
USP is now accepting applications from people who want to train at the $2 million center.
Pfizer is taking a unique tack in its fight against the counterfeit Viagra sold by Internet pharmacies that rob it of business: selling the drug online itself.
The FDA has been fighting assaults on the pharma supply chain on two major fronts: outright counterfeits and foreign-made versions of drugs. Now a hybrid has appeared: an unapproved, foreign version of Allergan's cosmetic treatment Botox in counterfeit packaging
One of the key players in an investigation of counterfeit Avastin that appeared to have been imported into the U.S. by a Canadian Internet pharmacy has pleaded guilty to playing a part in the operation.
California biotech and university researchers have come up with a process to synthesize artemisinin in efforts to both create a steady supply and stabilize the cost.